 | • レポートコード：B-GIR08C2862 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ヒトロタウイルスワクチンの世界市場について調べ、まとめました。種類別セグメントは、ロタリックス、ロタテック、Rotavac、Rotavin-M1、Lanzhou lamb等、用途別セグメントは、病院、診療所、学術研究、その他等に区分しました。ヒトロタウイルスワクチンの世界市場概観、企業動向、企業別ヒトロタウイルスワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ヒトロタウイルスワクチンの市場概観 ・ヒトロタウイルスワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ヒトロタウイルスワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・ヒトロタウイルスワクチンの世界市場規模 ・ヒトロタウイルスワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・ヒトロタウイルスワクチンのアメリカ市場規模推移 ・ヒトロタウイルスワクチンのカナダ市場規模推移 ・ヒトロタウイルスワクチンのメキシコ市場規模推移 ・ヒトロタウイルスワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ヒトロタウイルスワクチンのドイツ市場規模推移 ・ヒトロタウイルスワクチンのイギリス市場規模推移 ・ヒトロタウイルスワクチンのロシア市場規模推移 ・ヒトロタウイルスワクチンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ヒトロタウイルスワクチンの日本市場規模推移 ・ヒトロタウイルスワクチンの中国市場規模推移 ・ヒトロタウイルスワクチンの韓国市場規模推移 ・ヒトロタウイルスワクチンのインド市場規模推移 ・ヒトロタウイルスワクチンの東南アジア市場規模推移 ・ヒトロタウイルスワクチンの南米市場分析（ブラジル、アルゼンチン等） ・ヒトロタウイルスワクチンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ヒトロタウイルスワクチンの種類別分析/販売量、売上、市場シェア（ロタリックス、ロタテック、Rotavac、Rotavin-M1、Lanzhou lamb） ・ヒトロタウイルスワクチンの用途別分析/市場規模（病院、診療所、学術研究、その他） ・ヒトロタウイルスワクチンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ヒトロタウイルスワクチンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Human Rotavirus Vaccine is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Human Rotavirus Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Merck & Co., Inc.
Bharat Biotech
GlaxoSmithKline plc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Market Segment by Applications, can be divided into
Hospitals
Clinics
Academic and Research
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rotavirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Rotavirus Vaccine, with price, sales, revenue and global market share of Human Rotavirus Vaccine in 2017 and 2018.
Chapter 3, the Human Rotavirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Human Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Human Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Human Rotavirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Rotarix
1.2.2 RotaTeq
1.2.3 Rotavac
1.2.4 Rotavin-M1
1.2.5 Lanzhou lamb
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Academic and Research
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck & Co., Inc.
2.1.1 Business Overview
2.1.2 Human Rotavirus Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck & Co., Inc. Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bharat Biotech
2.2.1 Business Overview
2.2.2 Human Rotavirus Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bharat Biotech Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline plc.
2.3.1 Business Overview
2.3.2 Human Rotavirus Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline plc. Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Human Rotavirus Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Human Rotavirus Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Human Rotavirus Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Rotavirus Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Human Rotavirus Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Human Rotavirus Vaccine Market Analysis by Regions
4.1 Global Human Rotavirus Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Human Rotavirus Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Human Rotavirus Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
5 North America Human Rotavirus Vaccine by Country
5.1 North America Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Human Rotavirus Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America Human Rotavirus Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
6 Europe Human Rotavirus Vaccine by Country
6.1 Europe Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Human Rotavirus Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Human Rotavirus Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
6.3 UK Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
6.4 France Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Human Rotavirus Vaccine by Country
7.1 Asia-Pacific Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Human Rotavirus Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Human Rotavirus Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
7.5 India Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
8 South America Human Rotavirus Vaccine by Country
8.1 South America Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Human Rotavirus Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America Human Rotavirus Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Human Rotavirus Vaccine by Countries
9.1 Middle East and Africa Human Rotavirus Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Human Rotavirus Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Human Rotavirus Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
10 Global Human Rotavirus Vaccine Market Segment by Type
10.1 Global Human Rotavirus Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Human Rotavirus Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global Human Rotavirus Vaccine Revenue and Market Share by Type (2014-2019)
10.2 Rotarix Sales Growth and Price
10.2.1 Global Rotarix Sales Growth (2014-2019)
10.2.2 Global Rotarix Price (2014-2019)
10.3 RotaTeq Sales Growth and Price
10.3.1 Global RotaTeq Sales Growth (2014-2019)
10.3.2 Global RotaTeq Price (2014-2019)
10.4 Rotavac Sales Growth and Price
10.4.1 Global Rotavac Sales Growth (2014-2019)
10.4.2 Global Rotavac Price (2014-2019)
10.5 Rotavin-M1 Sales Growth and Price
10.5.1 Global Rotavin-M1 Sales Growth (2014-2019)
10.5.2 Global Rotavin-M1 Price (2014-2019)
10.6 Lanzhou lamb Sales Growth and Price
10.6.1 Global Lanzhou lamb Sales Growth (2014-2019)
10.6.2 Global Lanzhou lamb Price (2014-2019)
11 Global Human Rotavirus Vaccine Market Segment by Application
11.1 Global Human Rotavirus Vaccine Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Clinics Sales Growth (2014-2019)
11.4 Academic and Research Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Human Rotavirus Vaccine Market Forecast (2019-2024)
12.1 Global Human Rotavirus Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 Human Rotavirus Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America Human Rotavirus Vaccine Market Forecast (2019-2024)
12.2.2 Europe Human Rotavirus Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Human Rotavirus Vaccine Market Forecast (2019-2024)
12.2.4 South America Human Rotavirus Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Human Rotavirus Vaccine Market Forecast (2019-2024)
12.3 Human Rotavirus Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global Human Rotavirus Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global Human Rotavirus Vaccine Market Share Forecast by Type (2019-2024)
12.4 Human Rotavirus Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global Human Rotavirus Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global Human Rotavirus Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Human Rotavirus Vaccine Picture
Table Product Specifications of Human Rotavirus Vaccine
Figure Global Sales Market Share of Human Rotavirus Vaccine by Types in 2018
Table Human Rotavirus Vaccine Types for Major Manufacturers
Figure Rotarix Picture
Figure RotaTeq Picture
Figure Rotavac Picture
Figure Rotavin-M1 Picture
Figure Lanzhou lamb Picture
Figure Human Rotavirus Vaccine Sales Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Academic and Research Picture
Figure Others Picture
Figure United States Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure France Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure UK Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure China Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure India Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Human Rotavirus Vaccine Revenue (Value) and Growth Rate (2014-2024)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Human Rotavirus Vaccine Type and Applications
Table Merck & Co., Inc. Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table Bharat Biotech Human Rotavirus Vaccine Type and Applications
Table Bharat Biotech Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc. Human Rotavirus Vaccine Type and Applications
Table GlaxoSmithKline plc. Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Human Rotavirus Vaccine Sales by Manufacturer (2017-2018)
Figure Global Human Rotavirus Vaccine Sales Market Share by Manufacturer in 2017
Figure Global Human Rotavirus Vaccine Sales Market Share by Manufacturer in 2018
Table Global Human Rotavirus Vaccine Revenue by Manufacturer (2017-2018)
Figure Global Human Rotavirus Vaccine Revenue Market Share by Manufacturer in 2017
Figure Global Human Rotavirus Vaccine Revenue Market Share by Manufacturer in 2018
Figure Top 3 Human Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Human Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2018
Figure Global Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Global Human Rotavirus Vaccine Revenue and Growth Rate (2014-2019)
Table Global Human Rotavirus Vaccine Sales by Regions (2014-2019)
Table Global Human Rotavirus Vaccine Sales Market Share by Regions (2014-2019)
Table Global Human Rotavirus Vaccine Revenue by Regions (2014-2019)
Figure Global Human Rotavirus Vaccine Revenue Market Share by Regions in 2014
Figure Global Human Rotavirus Vaccine Revenue Market Share by Regions in 2018
Figure North America Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Europe Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure South America Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure North America Human Rotavirus Vaccine Revenue and Growth Rate (2014-2019)
Table North America Human Rotavirus Vaccine Sales by Countries (2014-2019)
Table North America Human Rotavirus Vaccine Sales Market Share by Countries (2014-2019)
Figure North America Human Rotavirus Vaccine Sales Market Share by Countries in 2014
Figure North America Human Rotavirus Vaccine Sales Market Share by Countries in 2018
Table North America Human Rotavirus Vaccine Revenue by Countries (2014-2019)
Table North America Human Rotavirus Vaccine Revenue Market Share by Countries (2014-2019)
Figure North America Human Rotavirus Vaccine Revenue Market Share by Countries in 2014
Figure North America Human Rotavirus Vaccine Revenue Market Share by Countries in 2018
Figure United States Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Canada Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Mexico Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Europe Human Rotavirus Vaccine Revenue and Growth Rate (2014-2019)
Table Europe Human Rotavirus Vaccine Sales by Countries (2014-2019)
Table Europe Human Rotavirus Vaccine Sales Market Share by Countries (2014-2019)
Table Europe Human Rotavirus Vaccine Revenue by Countries (2014-2019)
Figure Europe Human Rotavirus Vaccine Revenue Market Share by Countries in 2017
Figure Europe Human Rotavirus Vaccine Revenue Market Share by Countries in 2018
Figure Germany Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure UK Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure France Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Russia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Italy Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Human Rotavirus Vaccine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Human Rotavirus Vaccine Sales by Countries (2014-2019)
Table Asia-Pacific Human Rotavirus Vaccine Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Human Rotavirus Vaccine Sales Market Share by Countries 2018
Table Asia-Pacific Human Rotavirus Vaccine Revenue by Countries (2014-2019)
Figure Asia-Pacific Human Rotavirus Vaccine Revenue Market Share by Countries 2018
Figure China Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Japan Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Korea Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure India Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Southeast Asia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure South America Human Rotavirus Vaccine Revenue and Growth Rate (2014-2019)
Table South America Human Rotavirus Vaccine Sales by Countries (2014-2019)
Table South America Human Rotavirus Vaccine Sales Market Share by Countries (2014-2019)
Figure South America Human Rotavirus Vaccine Sales Market Share by Countries in 2018
Table South America Human Rotavirus Vaccine Revenue by Countries (2014-2019)
Table South America Human Rotavirus Vaccine Revenue Market Share by Countries (2014-2019)
Figure South America Human Rotavirus Vaccine Revenue Market Share by Countries in 2018
Figure Brazil Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Argentina Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Colombia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Human Rotavirus Vaccine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Human Rotavirus Vaccine Sales by Countries (2014-2019)
Table Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Countries in 2018
Table Middle East and Africa Human Rotavirus Vaccine Revenue by Countries (2014-2019)
Table Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Countries in 2014
Figure Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Countries in 2018
Figure Saudi Arabia Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure UAE Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Egypt Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure Nigeria Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Figure South Africa Human Rotavirus Vaccine Sales and Growth Rate (2014-2019)
Table Global Human Rotavirus Vaccine Sales by Type (2014-2019)
Table Global Human Rotavirus Vaccine Sales Share by Type (2014-2019)
Table Global Human Rotavirus Vaccine Revenue by Type (2014-2019)
Table Global Human Rotavirus Vaccine Revenue Share by Type (2014-2019)
Figure Global Rotarix Sales Growth (2014-2019)
Figure Global Rotarix Price (2014-2019)
Figure Global RotaTeq Sales Growth (2014-2019)
Figure Global RotaTeq Price (2014-2019)
Figure Global Rotavac Sales Growth (2014-2019)
Figure Global Rotavac Price (2014-2019)
Figure Global Rotavin-M1 Sales Growth (2014-2019)
Figure Global Rotavin-M1 Price (2014-2019)
Figure Global Lanzhou lamb Sales Growth (2014-2019)
Figure Global Lanzhou lamb Price (2014-2019)
Table Global Human Rotavirus Vaccine Sales by Application (2014-2019)
Table Global Human Rotavirus Vaccine Sales Share by Application (2014-2019)
Figure Global Clinics Sales Growth (2014-2019)
Figure Global Academic and Research Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Human Rotavirus Vaccine Sales, Revenue and Growth Rate (2019-2024)
Table Global Human Rotavirus Vaccine Sales Forecast by Regions (2019-2024)
Table Global Human Rotavirus Vaccine Market Share Forecast by Regions (2019-2024)
Figure North America Sales Human Rotavirus Vaccine Market Forecast (2019-2024)
Figure Europe Sales Human Rotavirus Vaccine Market Forecast (2019-2024)
Figure Asia-Pacific Sales Human Rotavirus Vaccine Market Forecast (2019-2024)
Figure South America Sales Human Rotavirus Vaccine Market Forecast (2019-2024)
Figure Middle East and Africa Sales Human Rotavirus Vaccine Market Forecast (2019-2024)
Table Global Human Rotavirus Vaccine Sales Forecast by Type (2019-2024)
Table Global Human Rotavirus Vaccine Market Share Forecast by Type (2019-2024)
Table Global Human Rotavirus Vaccine Sales Forecast by Application (2019-2024)
Table Global Human Rotavirus Vaccine Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
経口ロタウイルスワクチン市場：世界及び中国市場分析・予測（～2024年） Oral Rotavirus Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Oral Rotavirus Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Oral Rotavirus Vaccine m…- 人間用予防ワクチンの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Prophylactic Human Vaccine is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Prophylactic Human Vac…
- 凍結乾燥BCGワクチンの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Freeze-Dried BCG Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Freeze-Dried B…
- ワクチンキャリアの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Vaccine Carrier is an innovative insulated packaging used for the transportation of Vaccine at controlled temperatures. It efficiently preserves the products from thermal and physical shocks, and most pathogens cannot survive at sub-zero temperatures. Scope of the Report: Field trials of large capac…
- ジカウイルスワクチンの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Zika Virus Vaccines is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Zika Virus Vaccines in global…